In the latest edition of STAT Health Tech: a fresh round of acquisitions, 23andMe’s cancer drug trials, and Oak Street Health’s expansion.
In the latest edition of STAT Health Tech: a fresh round of acquisitions, 23andMe’s cancer drug trials, and Oak Street Health’s expansion.